Entera Bio Ltd.

NASDAQ:ENTX

Biotechnology

Healthcare
$3.28 +0.00%

+$0.00 today

Market cap
$571.17M
Beta
1.49
P/E (TTM)
-4.6
EPS (TTM)
-$0.26
52W Low $0.91High $3.22

Volume 0.23M

Average 0.16M

Balance Sheet

Inspect the capital base behind the business.

Assets

$15.99M

FY 2025 · Annual

+70.3% YoY

Liabilities

$2.89M

FY 2025 · Annual

+120.8% YoY

Equity

$13.10M

FY 2025 · Annual

+62.1% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents24.89M12.31M11.02M8.66M7.11M
Short-term Investments00000
Net Receivables183K246K0126K219K
Inventory00000
Other Current Assets254K294K238K186K(219K)
Total Current Assets25.33M12.85M11.26M8.97M7.11M
Property, Plant & Equipment (Net)395K229K488K332K134K
Goodwill00000
Intangible Assets00000
Long-term Investments00080K90K
Tax Assets217K43K14K00
Other Non-current Assets46K6K6K6K(90K)
Total Non-current Assets658K278K508K418K134K
Total Assets25.99M13.13M11.77M9.39M15.99M
Account Payables166K17K83K132K448K
Short-term Debt00000
Tax Payables134K0000
Deferred Revenue15K0000
Other Current Liabilities455K300K500K339K432K
Total Current Liabilities3.16M1.34M1.09M1.18M2.2M
Long-term Debt0000260K
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities138K32K32K32K429K
Total Non-current Liabilities261K32K288K134K689K
Total Liabilities3.42M1.37M1.38M1.31M2.89M
Common Stock001K1K1K
Retained Earnings(82.43M)(95.5M)(104.39M)(113.93M)(125.37M)
Accumulated OCI41K41K41K41K41K
Other Stockholders Equity00000
Minority Interest00000
Total Equity22.57M11.75M10.39M8.08M13.1M
Total Debt302K91K390K272K490K
Net Debt(24.59M)(12.22M)(10.63M)(8.39M)(6.62M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$4.1M
Other Current$8.4M
Total Current Assets$12.5M
PP&E (Net)$540.0K
Other Non-current$96.0K
Total Non-current Assets$636.0K
Total Assets$13.1M

Analysis

Selected assets total $13.1M for Latest. The largest visible component is Other Current at $8.4M, about 63.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 13, 2026
10-QQuarterly reportNov 6, 2026
8-KCurrent reportNov 6, 2026
SC 13GSC 13G filingOct 30, 2026
8-KCurrent reportOct 27, 2026

How much cash does ENTX have?

Entera Bio Ltd. (ENTX) reported $7.11M in cash and equivalents in fiscal 2025.

How much debt does ENTX carry?

Entera Bio Ltd. (ENTX) reported $490,000.00 of total debt, with net debt of -$6.62M.